TY  - GEN
AU  - Schiller,Gary J
AU  - O'Brien,Susan M
AU  - Pigneux,Arnaud
AU  - Deangelo,Daniel J
AU  - Vey,Norbert
AU  - Kell,Jonathan
AU  - Solomon,Scott
AU  - Stuart,Robert K
AU  - Karsten,Verena
AU  - Cahill,Ann L
AU  - Albitar,Maher X
AU  - Giles,Francis J
TI  - Single-agent laromustine, a novel alkylating agent, has significant activity in older patients with previously untreated poor-risk acute myeloid leukemia
SN  - 1527-7755
PY  - 2010///0304
KW  - Age Factors
KW  - Aged
KW  - Aged, 80 and over
KW  - Antineoplastic Agents, Alkylating
KW  - administration & dosage
KW  - Comorbidity
KW  - Europe
KW  - epidemiology
KW  - Female
KW  - Gene Expression Regulation, Leukemic
KW  - Heart Diseases
KW  - mortality
KW  - Humans
KW  - Hydrazines
KW  - Infusions, Intravenous
KW  - Kaplan-Meier Estimate
KW  - Karyotyping
KW  - Leukemia, Myeloid, Acute
KW  - drug therapy
KW  - Liver Diseases
KW  - Lung Diseases
KW  - Male
KW  - Middle Aged
KW  - Prospective Studies
KW  - Risk Assessment
KW  - Risk Factors
KW  - Sulfonamides
KW  - Treatment Outcome
KW  - United States
N1  - Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study
UR  - https://doi.org/10.1200/JCO.2009.24.2008
ER  -